Abstract:Abstract Abstract 4709 Objective: As granulocyte colony-stimulating factor, recombinant human granulocyte colony stimulating factor (rhG-CSF) is widely used in neutropenic patients. In addition to stimulating the growth of granulocyte, rhG-CSF can promote hematopoietic stem cells from bone marrow (BM) to peripheral blood (PB) and has the effect of immune regulation. Myeloid-derived suppressor cells (MDSC) are a group of heterogeneous cells, derived from bone marrow progenitor cells and immature myeloid cells. Recently, MDSC is researched in the field of solid tumor, but not in the field of hematopoietic stem cell transplantation. Here, we investigate rhG-CSF's effect on MDSC in healthy donors’ BM, PB and the relationship between MDSC and graft-verse-host disease (GVHD). Methods: We obtained the BM and PB samples before mobilization and the BM APB and peripheral blood stem cell collection (PBSC) on the 5th day after the rhG-CSF mobilization from 12 healthy donors, respectively. Then we used the flow cytometry to check the absolute number of MDSC. Finally, we analyzed the relationship between the number of MDSC and the incidence of GVHD. Results: In normal physiological conditions, the MDSC could be detected in healthy donor's PB and BM. In PB, the proportion of MDSC in the mononuclear cells was 1.35 ± 0.35%. In BM, the proportion was 2.44 ± 1.11%. The proportion in BM is higher than that in PB, the difference was statistically significant (P=0.047). On the 5th day after the rhG-CSF mobilization, the MDSC ratio of mononuclear cell in PB were 4.01 ± 1.82%. In BM, the ratio was 4.38 ± 2.19%. The difference between the ratio of MDSC in BM and PB was no significant (P=0.076). The number of mobilized peripheral blood MDSC was significantly higher than that before mobilization (P=0.015), while the difference between the numbers of bone marrow MDSC cells before and after mobilization was not significant (P=0.083). The numbers of MDSC in collection and the incidence of GVHD had a significant negative correlation (P=0.048). Conclusion: MDSC could be detected in the healthy donors’ PB and BM, the numbers of MDSC in BM were higher than that in PB. The rhG-CSF could mobilize more MDSC from BM to the peripheral blood, and the increased s of MDSC in PB after rhG-CSF mobilization might be related to the low incidence of GVHD in hematopoietic stem cell transplantation. Supported by National Natural Science Foundation of China (30971300), Science and Technology Planning Project of Guangdong Province of China (2009A030200007) and China Postdoctoral Science Foundation (200902332, 20080440776). Disclosures: No relevant conflicts of interest to declare.

[Effect of Bone Marrow Graft Collection on Composition of Peripheral Blood Stem Cell Grafts from Healthy Donors after Recombinant Human Granulocyte Colony-Stimulating Factor Application in Vivo for Mobilization].

[Short-Term Effects of Hemogram in Healthy Donors after Peripheral Blood Stem Cell Collection].

[CD34 Cells and T Cell Subsets in Recombinant Human Granulocyte Colony-Stimulating Factor Primed Bone Marrow Grafts from Donors with Different Characteristics].

Effects of rhG-CSF mobilization on immunological characteristics of peripheral blood grafts and steady-state bone marrow

[Factors Affecting Mobilization of Peripheral Blood Stem/progenitor Cells and Apheresis Efficiency from Healthy Donors by Rhg-Csf].

Influence of Recombinant Human Granulocyte Colony Stimulating Factor (Rhg-Csf) on CD34+ Hematopoietic Stem Cells and Regulatory T Cells in Healthy Donors

Investigation on related factors of CD 34+ cells in peripheral blood mobilization effect by G-SCF stimulation

The Effect of Rhg-CSF on MDSC in Bone Marrow and Peripheral Blood Cells

Peripheral Blood Stem Cell Mobilization with Low Dose Rhg-Csf in 56 Unrelated Healthy Donors

[Effects of Rhg-Csf Mobilization on Immunological Properties of Grafts from Peripheral Blood and Bone Marrow].

Modulation of Adhesion Molecule Expression on T Cells in Bone Marrow after in Vivo Rhg-Csf Application

Clinical Analysis on the Mobilization and Collection of Peripheral Hematopoietic Stem Cells in 198 Healthy Donors

Efffects of Rhg-Csf on Healthy Donors

[Effect of Granulocyte Colony Stimulating Factor on Myeloid-Derived Suppressor Cells in the Bone Marrow and Peripheral Blood: a Preliminary Study].

Effect of the in vivo application of granulocyte colony-stimulating factor on NK cells in bone marrow and peripheral blood.

Correlation of monocyte counts prior to the collection of recombinant human granulocyte colony-stimulating factor primed bone marrow grafts with the quantities of CD34~+ cells in the grafts.

A comparison of hematopoietic and immunological characteristics of granulocyte colony-stimulating factor primed bone marrow grafts between pediatric and adult donors

The Effect of Granulocyte Colony-Stimulating Factor on Immune-Modulatory Cytokines in the Bone Marrow Microenvironment and Mesenchymal Stem Cells of Healthy Donors

Stem cell collection in unmanipulated HLA-haploidentical/mismatched related transplantation with combined granulocyte-colony stimulating factor-mobilised blood and bone marrow for patients with haematologic malignancies: the impact of donor characteristics and procedural settings

Effect of Rhg-Csf Mobilized Peripheral Blood and Bone Marrow after Being Mixed in Different Proportions on Immunologic Properties of Grafts

Effect of dexamethasone on G-CSF mobilization of peripheral blood stem cells in healthy donors and hematopoietic reconstruction in the recipients]